gip/glp 1-agonist tirzepatide Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction Mechanisms of action of GLP-1
Pay in 4 interest-free payments of $5.32 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16












:max_bytes(150000):strip_icc()/GettyImages-1393287140-1a0a64aa9b8f4abc85356e41c0f799a2.jpg)












